898 related articles for article (PubMed ID: 31060824)
21. Cost-effectiveness of minimally invasive partial nephrectomy and percutaneous cryoablation for cT1a renal cell carcinoma.
Wu X; Uhlig J; Shuch BM; Uhlig A; Kim HS
Eur Radiol; 2023 Mar; 33(3):1801-1811. PubMed ID: 36329348
[TBL] [Abstract][Full Text] [Related]
22. Local ablation vs partial nephrectomy in T1N0M0 renal cell carcinoma: An inverse probability of treatment weighting analysis.
Shi L; He Y; Liu C; Qian X; Wang Z
Cancer Med; 2020 Nov; 9(21):7988-8003. PubMed ID: 32888392
[TBL] [Abstract][Full Text] [Related]
23. Outcomes of Renal Tumors Treated by Image-Guided Percutaneous Cryoablation: Immediate and 3- and 5-Year Outcomes at a Regional Center.
Lim E; Kumar S; Seager M; Modi S; Mandal I; Neves JB; Jones S; Tran MGB; Munneke G; Bandula S; Walkden M
AJR Am J Roentgenol; 2020 Jul; 215(1):242-247. PubMed ID: 32286877
[No Abstract] [Full Text] [Related]
24. Radical Versus Partial Nephrectomy for cT1 Renal Cell Carcinoma.
Gershman B; Thompson RH; Boorjian SA; Lohse CM; Costello BA; Cheville JC; Leibovich BC
Eur Urol; 2018 Dec; 74(6):825-832. PubMed ID: 30262341
[TBL] [Abstract][Full Text] [Related]
25. Laparoscopic renal cryoablation using ultrathin 17-gauge cryoprobes: mid-term oncological and functional results.
Beemster PW; Barwari K; Mamoulakis C; Wijkstra H; de la Rosette JJ; Laguna MP
BJU Int; 2011 Aug; 108(4):577-82. PubMed ID: 21044249
[TBL] [Abstract][Full Text] [Related]
26. Safety and Oncologic Outcomes of Percutaneous Cryoablation of Renal Cell Carcinoma Recurrences in the Ipsilateral Kidney Following Partial Nephrectomy.
Rossi J; Cazzato RL; de Marini P; Auloge P; Autrusseau PA; Dalili D; Tricard T; Poussot B; Garnon J; Lang H; Gangi A
Cardiovasc Intervent Radiol; 2022 May; 45(5):656-664. PubMed ID: 35274173
[TBL] [Abstract][Full Text] [Related]
27. Image-guided Cryoablation for Sporadic Renal Cell Carcinoma: Three- and 5-year Outcomes in 220 Patients with Biopsy-proven Renal Cell Carcinoma.
Breen DJ; King AJ; Patel N; Lockyer R; Hayes M
Radiology; 2018 Nov; 289(2):554-561. PubMed ID: 30084744
[TBL] [Abstract][Full Text] [Related]
28. Does the Unexpected Presence of Non-organ-confined Disease at Final Pathology Undermine Cancer Control in Patients with Clinical T1N0M0 Renal Cell Carcinoma Who Underwent Partial Nephrectomy?
Capitanio U; Stewart GD; Klatte T; Akdogan B; Roscigno M; Marszalek M; Dell'Oglio P; Zaffuto E; Rodriguez Faba O; Salagierski M; Lingard J; Carini M; Ouzaid I; Mir MC; Montorsi F; Da Pozzo LF; Stief C; Minervini A; Brookman-May SD
Eur Urol Focus; 2018 Dec; 4(6):972-977. PubMed ID: 28753867
[TBL] [Abstract][Full Text] [Related]
29. A comparison of overall survival and perioperative outcomes between partial and radical nephrectomy for cT1b and cT2 renal cell carcinoma-Analysis of a national cancer registry.
Venkatramani V; Koru-Sengul T; Miao F; Nahar B; Prakash NS; Swain S; Punnen S; Ritch C; Gonzalgo M; Parekh D
Urol Oncol; 2018 Mar; 36(3):90.e9-90.e14. PubMed ID: 29254672
[TBL] [Abstract][Full Text] [Related]
30. Radiofrequency ablation versus cryoablation for T1b renal cell carcinoma: a multi-center study.
Hasegawa T; Yamanaka T; Gobara H; Miyazaki M; Takaki H; Sato Y; Inaba Y; Yamakado K
Jpn J Radiol; 2018 Sep; 36(9):551-558. PubMed ID: 29968201
[TBL] [Abstract][Full Text] [Related]
31. Five-year Oncologic Outcomes After Transperitoneal Robotic Partial Nephrectomy for Renal Cell Carcinoma.
Andrade HS; Zargar H; Caputo PA; Akca O; Kara O; Ramirez D; Haber GP; Stein RJ; Kaouk JH
Eur Urol; 2016 Jun; 69(6):1149-54. PubMed ID: 26719014
[TBL] [Abstract][Full Text] [Related]
32. Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma.
Psutka SP; Feldman AS; McDougal WS; McGovern FJ; Mueller P; Gervais DA
Eur Urol; 2013 Mar; 63(3):486-92. PubMed ID: 22959191
[TBL] [Abstract][Full Text] [Related]
33. Oncologic and Functional Outcomes of Radical and Partial Nephrectomy in pT3a Pathologically Upstaged Renal Cell Carcinoma: A Multi-institutional Analysis.
Patel SH; Uzzo RG; Larcher A; Peyronnet B; Lane BR; Pruthi D; Reddy M; Capitanio U; Joshi S; Noyes S; Eldefrawy A; Ghali F; Meagher MF; Hamilton ZA; Yim K; Nasseri R; Bradshaw AW; Dey S; Kirmiz S; Wan F; Liss MA; Bensalah K; Montorsi F; Derweesh IH
Clin Genitourin Cancer; 2020 Dec; 18(6):e723-e729. PubMed ID: 32600941
[TBL] [Abstract][Full Text] [Related]
34. Percutaneous Microwave Ablation versus Laparoscopic Partial Nephrectomy for cT1a Renal Cell Carcinoma: A Propensity-matched Cohort Study of 1955 Patients.
Yu J; Zhang X; Liu H; Zhang R; Yu X; Cheng Z; Han Z; Liu F; Hao G; Mu MJ; Liang P
Radiology; 2020 Mar; 294(3):698-706. PubMed ID: 31961239
[TBL] [Abstract][Full Text] [Related]
35. Renal functional outcomes in patients undergoing percutaneous cryoablation or partial nephrectomy for a solitary renal mass.
Mason RJ; Atwell TD; Lohse C; Bhindi B; Weisbrod A; Boorjian SA; Leibovich BC; Schmit GD; Thompson RH
BJU Int; 2017 Oct; 120(4):544-549. PubMed ID: 28548236
[TBL] [Abstract][Full Text] [Related]
36. Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors.
Kaushik D; Kim SP; Childs MA; Lohse CM; Costello BA; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
Eur Urol; 2013 Oct; 64(4):600-6. PubMed ID: 23280319
[TBL] [Abstract][Full Text] [Related]
37. Thermal ablation of small renal masses: intermediate outcomes from a Canadian center.
Erdeljan P; Dhar M; Wignall G; Kozak R; Pautler SE
Can J Urol; 2011 Oct; 18(5):5903-7. PubMed ID: 22018153
[TBL] [Abstract][Full Text] [Related]
38. A Comparison of Cryoablation with Heat-Based Thermal Ablation for Treatment of Clinical T1a Renal Cell Carcinoma: A National Cancer Database Study.
Wu J; Chang J; Bai HX; Su C; Zhang PJ; Karakousis G; Reddy S; Hunt S; Soulen MC; Stavropoulos SW; Zhang Z
J Vasc Interv Radiol; 2019 Jul; 30(7):1027-1033.e3. PubMed ID: 31176590
[TBL] [Abstract][Full Text] [Related]
39. Tumor Growth Kinetics and Oncologic Outcomes of Patients Undergoing Active Surveillance for Residual Renal Tumor following Percutaneous Thermal Ablation.
Chen JX; Maass D; Guzzo TJ; Bruce Malkowicz S; Wein AJ; Soulen MC; Clark TWI; Nadolski GJ; William Stavropoulos S
J Vasc Interv Radiol; 2016 Sep; 27(9):1397-1406. PubMed ID: 27234485
[TBL] [Abstract][Full Text] [Related]
40. Percutaneous ablation or minimally invasive partial nephrectomy for cT1a renal masses? A propensity score-matched analysis.
Bianchi L; Chessa F; Piazza P; Ercolino A; Mottaran A; Recenti D; Serra C; Gaudiano C; Cappelli A; Modestino F; Golfieri R; Bertaccini A; Marcelli E; Porreca A; Celia A; Schiavina R
Int J Urol; 2022 Mar; 29(3):222-228. PubMed ID: 34894001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
